Ginkgo Bioworks (DNA) Q4 2024 Annual Earnings
DNA·Reported February 25, 2025·After market close
Ginkgo Bioworks reported Q4 2024 revenue of $43.8M, beat analyst consensus of $38.7M by $5.2M. Diluted EPS came in at $-1.82, missed the $-1.45 consensus by $0.37.
Revenue
$43.8Mbeat by $5.2M
Consensus: $38.7MDiluted EPS
$-1.82missed by $0.37
Consensus: $-1.45
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Ginkgo Bioworks's Q4 2024 earnings report.
Ginkgo Bioworks (DNA) reported Q4 2024 earnings on February 25, 2025 after market close.
Ginkgo Bioworks reported revenue of $43.8M and diluted EPS of $-1.82 for Q4 2024.
Revenue beat the consensus estimate of $38.7M by $5.2M. EPS missed the consensus estimate of $-1.45 by $0.37.
You can read the 10-K periodic report (0001628280-25-007819) directly on SEC EDGAR. The filing index links above go to sec.gov.